Kiadis Pharma Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
103
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$24.3M
Kiadis Pharma General Information
Description
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.
Contact Information
Website
www.kiadis.comCorporate Office
- Paasheuvelweg 25A
- Duivendrecht
- 1105 BP Amsterdam
- Netherlands
Corporate Office
- Paasheuvelweg 25A
- Duivendrecht
- 1105 BP Amsterdam
- Netherlands
Kiadis Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Merger/Acquisition | 22-Jan-2021 | $24.3M | Completed | Generating Revenue | ||
| 14. PIPE | 30-Apr-2020 | Completed | Generating Revenue | |||
| 13. PIPE | 31-May-2019 | Completed | Generating Revenue | |||
| 12. PIPE | 19-Oct-2018 | Completed | Generating Revenue | |||
| 11. Debt - General | 01-Jul-2018 | Completed | Generating Revenue | |||
| 10. Debt - General | 01-Aug-2017 | Completed | ||||
| 9. PIPE | 15-Jun-2017 | Completed | Generating Revenue | |||
| 8. Grant | 01-Feb-2016 | Completed | Generating Revenue | |||
| 7. IPO | 02-Jul-2015 | $36.4M | $76.9M | Completed | Generating Revenue | |
| 6. Grant | 26-Jun-2013 | $3.95M | $40.5M | Completed | Generating Revenue |
Kiadis Pharma Comparisons
Industry
Financing
Details
Kiadis Pharma Competitors (33)
One of Kiadis Pharma’s 33 competitors is TME Pharma, a Formerly VC-backed company based in Berlin, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TME Pharma | Formerly VC-backed | Berlin, Germany | ||||
| Monopar Therapeutics | Formerly VC-backed | Wilmette, IL | ||||
| Affimed | Formerly VC-backed | Mannheim, Germany | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Agenus | Formerly VC-backed | Lexington, MA |
Kiadis Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kiadis Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kiadis Pharma Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alafi Capital Company | Venture Capital | Minority | ||
| Alta Partners | Venture Capital | Minority | ||
| BioVeda Capital | Venture Capital | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| GeneChem | Venture Capital | Minority |
Kiadis Pharma Acquisitions (2)
Kiadis Pharma’s most recent deal was a Merger/Acquisition with CytoSen Therapeutics for . The deal was made on 06-Jun-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CytoSen Therapeutics | 06-Jun-2019 | Merger/Acquisition | Biotechnology | ||
| Celmed BioSciences | 28-Nov-2006 | Merger/Acquisition | Drug Discovery |
Kiadis Pharma ESG
Risk Overview
Risk Rating
Updated November, 08, 2026
13.5 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Kiadis Pharma FAQs
-
When was Kiadis Pharma founded?
Kiadis Pharma was founded in 1997.
-
Where is Kiadis Pharma headquartered?
Kiadis Pharma is headquartered in Amsterdam, Netherlands.
-
What is the size of Kiadis Pharma?
Kiadis Pharma has 103 total employees.
-
What industry is Kiadis Pharma in?
Kiadis Pharma’s primary industry is Drug Discovery.
-
Is Kiadis Pharma a private or public company?
Kiadis Pharma is a Private company.
-
What is the current valuation of Kiadis Pharma?
The current valuation of Kiadis Pharma is .
-
What is Kiadis Pharma’s current revenue?
The current revenue for Kiadis Pharma is .
-
How much funding has Kiadis Pharma raised over time?
Kiadis Pharma has raised $219M.
-
Who are Kiadis Pharma’s investors?
Alafi Capital Company, Alta Partners, BioVeda Capital, EQT Life Sciences, and GeneChem are 5 of 14 investors who have invested in Kiadis Pharma.
-
Who are Kiadis Pharma’s competitors?
TME Pharma, Monopar Therapeutics, Affimed, Immunocore Holdings, and Agenus are some of the 33 competitors of Kiadis Pharma.
-
When was Kiadis Pharma acquired?
Kiadis Pharma was acquired on 22-Jan-2021.
-
Who acquired Kiadis Pharma?
Kiadis Pharma was acquired by Sanofi.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
